Outsmarting Cancer to Deliver More Cures

CARGO is developing next-generation transformational CAR T-cell therapies with the mission of outsmarting cancer to deliver more cures for patients.

News

CARGO Therapeutics Names Kapil Dhingra, M.B.B.S., to Board of Directors
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-names-kapil-dhingra-mbbs-board-directors"
CARGO Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-reports-fourth-quarter-and-full-year-2023"
CARGO Therapeutics to Participate in the 44th Annual Cowen Healthcare Conference
Read More ⟶: "https://investors.cargo-tx.com/news-releases/news-release-details/cargo-therapeutics-participate-44th-annual-cowen-healthcare"

Life at CARGO

CARGO Therapeutics is Now Hiring. Join us to make a difference.
Open Positions ⟶